Company Filing History:
Years Active: 2024-2025
Title: Innovations by Sumeet K Mittal
Introduction
Sumeet K Mittal is a notable inventor based in Garden City, NY (US). He has made significant contributions to the field of medical research, particularly in the area of esophageal adenocarcinoma. With a total of two patents to his name, his work focuses on innovative methods for assessing and treating this serious condition.
Latest Patents
Sumeet K Mittal's latest patents include systems and methods for Barrett's esophagus pathogenesis and esophageal adenocarcinoma progression revealing markers. These methods provide a way to assess the risk of developing esophageal adenocarcinoma in a subject using various marker genes and proteins, including ISG15, LTF, CNDP2, DAD1, SET, UBE2N, S100P, and GPI. Additionally, the patents outline methods for determining the expression of esophageal adenocarcinoma risk factors, as well as strategies for treating and preventing the disease. The methods also focus on inhibiting the proliferation and migration of esophageal adenocarcinoma cells, and increasing susceptibility to cytotoxicity or inducing cell death in these cells.
Career Highlights
Sumeet K Mittal is currently associated with Prophase Labs, Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact the diagnosis and treatment of esophageal adenocarcinoma, contributing to better patient outcomes.
Collaborations
Some of his notable coworkers include Devendra K Agrawal and Joe Abdo, who collaborate with him in his research endeavors.
Conclusion
Sumeet K Mittal's contributions to medical research through his patents and work at Prophase Labs, Inc. highlight his commitment to advancing healthcare solutions. His innovative methods for addressing esophageal adenocarcinoma are paving the way for improved diagnostic and treatment options.